TY - JOUR
T1 - Changes in typical beliefs in response to complicated grief treatment
AU - Skritskaya, Natalia A.
AU - Mauro, Christine
AU - Garcia de la Garza, Angel
AU - Meichsner, Franziska
AU - Lebowitz, Barry
AU - Reynolds, Charles F.
AU - Simon, Naomi M.
AU - Zisook, Sidney
AU - Shear, M. Katherine
N1 - Funding Information:
Data used in this study were collected with support from grants from the National Institute of Mental Health (R01MH060783, R01MH085297, R01MH085308, and R01MH085288) and the American Foundation for Suicide Prevention (LSRG‐S‐172‐12).
Funding Information:
In the past 36 months, Naomi M. Simon reports the following: (a) research grants from the Department of Defense, NIH, PCORI, American Foundation for Suicide Prevention, and Janssen (b) speaking/CME/consulting from Axovant Sciences, Springworks, Praxis Therapeutics, and Aptinyx, Genomind, and (c) equity (spouse) from G1 Therapeutics. M. Katherine Shear reports a grant from NIMH and Christine Mauro reports a grant from NIMH during the conduct of the study. Natalia Skritskaya, Angel Garcia de la Garza, Franziska Meichsner, Barry Lebowitz, Charles F. Reynolds III, & Sidney Zisook have no conflicts of interest to report.
Publisher Copyright:
© 2019 Wiley Periodicals, Inc.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Background: Prolonged grief disorder (PGD) is a new diagnosis in the 11th edition of the International Classification of Diseases, estimated to affect 1 in 10 bereaved people and causing significant distress and impairment. Maladaptive thoughts play an important role in PGD. We have previously validated the typical beliefs questionnaire (TBQ), which contains five kinds of thinking commonly seen in PGD: protesting the death, negative thoughts about the world, needing the person, less grief is wrong, and grieving too much. The current paper examines the role of maladaptive cognition as measured by the TBQ in PGD and its change with treatment. Methods: Among participants in a multisite clinical trial including 394 adults, we examined (a) the relationship between maladaptive thoughts at baseline and treatment outcomes, (b) the relationship between maladaptive thoughts and suicidality at baseline and posttreatment, and (c) the effect of treatment with and without complicated grief therapy (CGT) on maladaptive thinking. Results: TBQ scores were associated with treatment outcomes and were strongly related to suicidal thinking before and after treatment. TBQ scores showed significantly greater reduction in participants who received CGT with citalopram versus citalopram alone (adjusted mean standard error [SE] difference, −2.45 [0.85]; p =.004) and those who received CGT with placebo versus placebo alone (adjusted mean [SE] difference, −3.44 [0.90]; p <.001). Conclusions: Maladaptive thoughts, as measured by the TBQ, have clinical and research significance for PGD and its treatment.
AB - Background: Prolonged grief disorder (PGD) is a new diagnosis in the 11th edition of the International Classification of Diseases, estimated to affect 1 in 10 bereaved people and causing significant distress and impairment. Maladaptive thoughts play an important role in PGD. We have previously validated the typical beliefs questionnaire (TBQ), which contains five kinds of thinking commonly seen in PGD: protesting the death, negative thoughts about the world, needing the person, less grief is wrong, and grieving too much. The current paper examines the role of maladaptive cognition as measured by the TBQ in PGD and its change with treatment. Methods: Among participants in a multisite clinical trial including 394 adults, we examined (a) the relationship between maladaptive thoughts at baseline and treatment outcomes, (b) the relationship between maladaptive thoughts and suicidality at baseline and posttreatment, and (c) the effect of treatment with and without complicated grief therapy (CGT) on maladaptive thinking. Results: TBQ scores were associated with treatment outcomes and were strongly related to suicidal thinking before and after treatment. TBQ scores showed significantly greater reduction in participants who received CGT with citalopram versus citalopram alone (adjusted mean standard error [SE] difference, −2.45 [0.85]; p =.004) and those who received CGT with placebo versus placebo alone (adjusted mean [SE] difference, −3.44 [0.90]; p <.001). Conclusions: Maladaptive thoughts, as measured by the TBQ, have clinical and research significance for PGD and its treatment.
KW - assessment/diagnosis
KW - cognition
KW - grief/bereavement/complicated grief
KW - suicide/self harm
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85076275653&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076275653&partnerID=8YFLogxK
U2 - 10.1002/da.22981
DO - 10.1002/da.22981
M3 - Article
C2 - 31804005
AN - SCOPUS:85076275653
SN - 1091-4269
VL - 37
SP - 81
EP - 89
JO - Depression and Anxiety
JF - Depression and Anxiety
IS - 1
ER -